UPDATED Feb 29, 2024
Defensive mid-caps and large-caps in descending order of expected ROE in three years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
4503Astellas Pharma | JP¥1,651.50 | 0.1% | -13.2% | JP¥3.0t | JP¥2,285.33 | PE705.4x | E40.8% | 4.2% | ||
4516Nippon Shinyaku | JP¥4,770.00 | -1.4% | -19.0% | JP¥321.3b | JP¥7,328.57 | PE13.3x | E11.1% | 2.6% | ||
4528Ono Pharmaceutical | JP¥2,488.00 | 2.7% | -10.7% | JP¥1.2t | JP¥2,689.17 | PE9.3x | E-6.2% | 3.2% | ||
4507Shionogi | JP¥7,484.00 | 4.7% | 25.3% | JP¥2.1t | JP¥7,628.46 | PE13.9x | E-1.1% | 2.0% | ||
4536Santen Pharmaceutical | JP¥1,486.50 | -3.8% | 46.3% | JP¥539.9b | JP¥1,727.78 | PE19.5x | E7.2% | 2.2% | ||
4523Eisai | JP¥6,254.00 | 1.5% | -16.3% | JP¥1.8t | JP¥8,521.43 | PE39.5x | E16.3% | 2.6% | ||
4502Takeda Pharmaceutical | JP¥4,387.00 | -1.1% | 4.9% | JP¥6.9t | JP¥4,742.78 | PE38.6x | E22.4% | 4.3% |